Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
||||||
GSE180825 |
ES-derived Dlx6a-Cre fate-mapped neuron bulk RNA-seq
|
4 |
|
Edmund Au | Dec 08, 2022 | |||
GSE181294 |
Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses
|
51 |
|
Shenglin Mei | Dec 08, 2022 | |||
GSE199737 |
PML nuclear bodies form a regulatory hub via liquid-liquid phase separation for TRIM33 control of Lefty1/2 genes in mouse embryonic stem cells [RNA-seq]
|
16 | Hongyao Sun | Dec 08, 2022 | ||||
GSE203387 |
RNAseq in Sirt1 wild-type or conditional KO mouse T-ALLs
|
10 | Daniel Herranz | Dec 08, 2022 | ||||
GSE219174 |
Cancer Cells Resistant to Immune Checkpoint Blockade Acquire Interferon-Associated Epigenetic Memory to Sustain T Cell Dysfunction (ATAC-Seq I)
|
16 |
|
Kathryn Tsai | Dec 08, 2022 | |||
GSE219175 |
Cancer Cells Resistant to Immune Checkpoint Blockade Acquire Interferon-Associated Epigenetic Memory to Sustain T Cell Dysfunction (ATAC-Seq II)
|
19 |
|
Kathryn Tsai | Dec 08, 2022 | |||
GSE219176 |
Cancer Cells Resistant to Immune Checkpoint Blockade Acquire Interferon-Associated Epigenetic Memory to Sustain T Cell Dysfunction (RNA-Seq)
|
16 |
|
Kathryn Tsai | Dec 08, 2022 | |||
GSE219178 |
Cancer Cells Resistant to Immune Checkpoint Blockade Acquire Interferon-Associated Epigenetic Memory to Sustain T Cell Dysfunction (CUTNRUN)
|
32 |
|
Kathryn Tsai | Dec 08, 2022 | |||
GSE220070 |
miRNA expression in plasma samples from Non-functional adenoma (NFA), Cortisol-producing adneoma (CPA)and primary bilateral macronodular adrenal hyperplasia (PBMAH)
|
14 | Masanori Murakami | Dec 08, 2022 | ||||
GSE220473 |
Developing & Optimizing Acute Myeloid Leukemia Specific Therapeutic Antibodies [CITE-seq]
|
18 | Simon J Hogg | Dec 08, 2022 |